MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
Li X, Roslan S, Johnstone CN, Wright JA, Bracken CP, Anderson M, Bert AG, Selth LA, Anderson RL, Goodall GJ, Gregory PA, Khew-Goodall Y.
Li X, et al. Among authors: anderson rl, anderson m.
Oncogene. 2014 Jul 31;33(31):4077-88. doi: 10.1038/onc.2013.370. Epub 2013 Sep 16.
Oncogene. 2014.
PMID: 24037528